UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15442) 15442
Book Chapter (116) 116
Magazine Article (33) 33
Dissertation (24) 24
Newspaper Article (15) 15
Book / eBook (7) 7
Newsletter (7) 7
Publication (7) 7
Reference (6) 6
Web Resource (6) 6
Book Review (5) 5
Conference Proceeding (5) 5
Paper (2) 2
Government Document (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10769) 10769
science & technology (9594) 9594
imatinib mesylate (9259) 9259
life sciences & biomedicine (9071) 9071
benzamides (6873) 6873
male (5056) 5056
pyrimidines - therapeutic use (4929) 4929
piperazines - therapeutic use (4757) 4757
female (4374) 4374
antineoplastic agents - therapeutic use (3913) 3913
oncology (3740) 3740
middle aged (3510) 3510
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (3461) 3461
animals (3205) 3205
adult (3049) 3049
aged (2611) 2611
hematology (2557) 2557
imatinib (2460) 2460
pyrimidines - pharmacology (2460) 2460
piperazines - pharmacology (2360) 2360
treatment outcome (1998) 1998
chronic myeloid leukemia (1709) 1709
protein kinase inhibitors - therapeutic use (1708) 1708
antineoplastic agents - pharmacology (1509) 1509
pyrimidines - administration & dosage (1447) 1447
protein-tyrosine kinases - antagonists & inhibitors (1401) 1401
leukemia, myelogenous, chronic, bcr-abl positive - genetics (1398) 1398
piperazines - administration & dosage (1364) 1364
mutation (1350) 1350
gastrointestinal stromal tumors - drug therapy (1288) 1288
mice (1273) 1273
pyrimidines - adverse effects (1219) 1219
piperazines - adverse effects (1142) 1142
pharmacology & pharmacy (1122) 1122
cancer (1118) 1118
drug resistance, neoplasm (1102) 1102
mesylates - pharmacology (1094) 1094
abridged index medicus (1089) 1089
leukemia (1089) 1089
leukemia, myelogenous, chronic, bcr-abl positive - pathology (1077) 1077
mesylates - chemistry (1066) 1066
fusion proteins, bcr-abl - genetics (1065) 1065
protein kinase inhibitors - pharmacology (996) 996
research (970) 970
antineoplastic agents - adverse effects (966) 966
cell line, tumor (952) 952
antineoplastic agents (940) 940
adolescent (927) 927
biochemistry & molecular biology (918) 918
hemic and lymphatic diseases (915) 915
antineoplastic agents - administration & dosage (903) 903
time factors (875) 875
aged, 80 and over (874) 874
care and treatment (871) 871
analysis (859) 859
prognosis (843) 843
imatinib mesylate - therapeutic use (824) 824
rats (817) 817
antimitotic agents (805) 805
dose-response relationship, drug (805) 805
benzamides - therapeutic use (773) 773
young adult (764) 764
apoptosis - drug effects (763) 763
gastrointestinal stromal tumors - pathology (726) 726
drug therapy (713) 713
cell biology (666) 666
medicine & public health (663) 663
dasatinib (660) 660
tyrosine (659) 659
proto-oncogene proteins c-kit - genetics (651) 651
fusion proteins, bcr-abl - metabolism (638) 638
chemistry (628) 628
physical sciences (586) 586
apoptosis (584) 584
tumors (573) 573
leukemia, myelogenous, chronic, bcr-abl positive - metabolism (572) 572
drug resistance, neoplasm - genetics (568) 568
retrospective studies (567) 567
remission induction (563) 563
mesylates (562) 562
follow-up studies (558) 558
neoplasms (555) 555
hematology, oncology and palliative medicine (547) 547
cell proliferation - drug effects (538) 538
disease-free survival (536) 536
fusion proteins, bcr-abl - antagonists & inhibitors (532) 532
k562 cells (525) 525
gastrointestinal stromal tumors - surgery (509) 509
antineoplastic combined chemotherapy protocols - therapeutic use (506) 506
imatinib mesylate - pharmacology (488) 488
kinases (487) 487
genetic aspects (485) 485
gastrointestinal stromal tumor (478) 478
molecular structure (476) 476
catalysis (471) 471
general & internal medicine (464) 464
health aspects (457) 457
signal transduction (455) 455
surgery (454) 454
philadelphia chromosome (452) 452
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14210) 14210
Japanese (465) 465
Chinese (324) 324
German (307) 307
French (286) 286
Italian (146) 146
Russian (99) 99
Spanish (95) 95
Portuguese (64) 64
Polish (42) 42
Korean (32) 32
Hungarian (27) 27
Czech (24) 24
Danish (12) 12
Croatian (10) 10
Swedish (10) 10
Dutch (9) 9
Bulgarian (5) 5
Turkish (5) 5
Finnish (3) 3
Hebrew (3) 3
Norwegian (3) 3
Romanian (3) 3
Serbian (3) 3
Slovak (3) 3
Ukrainian (3) 3
Indonesian (2) 2
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 03/2017, Volume 376, Issue 10, pp. 917 - 927
Journal Article
International journal of nanomedicine, ISSN 1176-9114, 2015, Volume 10, pp. 3163 - 3170
Journal Article
Molecular diversity, ISSN 1381-1991, 8/2019, Volume 23, Issue 3, pp. 723 - 738
A series of new urea/thiourea derivatives 3a–j were synthesized by simple addition reaction of functionalized phenyl isocyanates/isothiocyanates 2a–j with... 
Biochemistry, general | Antioxidant activity | Sulfonamide derivatives | Molecular docking | Life Sciences | Polymer Sciences | Antifungal activity | Carbamate derivatives | Pharmacy | Thiourea derivatives | Antibacterial activity | Urea derivatives | Organic Chemistry | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Applied | Pharmacology & Pharmacy | Chemistry, Medicinal | Chemistry, Multidisciplinary | Science & Technology | Chemistry Techniques, Synthetic | Antioxidants - chemistry | Sulfonamides - chemistry | Anti-Infective Agents - metabolism | Imatinib Mesylate - chemical synthesis | Imatinib Mesylate - pharmacology | Anti-Infective Agents - pharmacology | Antioxidants - metabolism | Aromatase - metabolism | Imatinib Mesylate - metabolism | Structure-Activity Relationship | Antioxidants - chemical synthesis | Antioxidants - pharmacology | Thiourea - chemistry | Imatinib Mesylate - chemistry | Anti-Infective Agents - chemical synthesis | Aromatase - chemistry | Carbamates - chemistry | Anti-Infective Agents - chemistry | Protein Conformation | Molecular Docking Simulation | Spectrum Analysis | Antioxidants | Antimitotic agents | Urea | Dichloropropane | Sulfonamides | Chlorides | Carbamates | Antineoplastic agents | Antibacterial agents | Isocyanates | Index Medicus
Journal Article
Journal Article
Drug design, development and therapy, ISSN 1177-8881, 07/2015, Volume 9, pp. 3961 - 3968
Objective: Cilostazol is a Biopharmaceutical Classification System class II drug with low solubility and high permeability, so its oral absorption is variable... 
Acid addition reaction | Cilostazol | Besylate | Mesylate | Dissolution | BCS class II | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Cardiovascular Agents - chemical synthesis | Area Under Curve | Mesylates - pharmacokinetics | Benzenesulfonates - chemical synthesis | Biological Availability | Male | Benzenesulfonates - administration & dosage | Tetrazoles - blood | Benzenesulfonates - pharmacokinetics | Wettability | Tetrazoles - administration & dosage | Cardiovascular Agents - pharmacokinetics | Benzenesulfonates - blood | Mesylates - blood | Cardiovascular Agents - administration & dosage | Gastrointestinal Absorption | Tetrazoles - chemical synthesis | Administration, Oral | Mesylates - administration & dosage | Drug Stability | Solubility | Technology, Pharmaceutical - methods | Rats, Sprague-Dawley | Chemistry, Pharmaceutical | Cardiovascular Agents - blood | Animals | Tetrazoles - pharmacokinetics | Mesylates - chemical synthesis | Drugs | Pharmaceutical research | Control | Structure-activity relationship (Pharmacology) | Bioavailability | Research | Structure-activity relationships | Salts | Drug delivery systems | Nuclear magnetic resonance--NMR | Hydrocarbons | pH effects | Magnetic resonance spectroscopy | Absorption | Humidity | Formulations | Hygroscopicity | Stability | Oral administration | Pharmacology | Permeability | Chromatography | Sulfonic acid | Studies | Acids | Magnetic permeability | Benzene | Benzenesulfonic acids | Physicochemical properties | Pharmaceuticals | Index Medicus | cilostazol | mesylate | acid addition reaction | besylate | dissolution
Journal Article